Protagonist Therapeutics (PTGX) Accumulated Depreciation & Amortization: 2017-2025
Historic Accumulated Depreciation & Amortization for Protagonist Therapeutics (PTGX) over the last 5 years, with Sep 2025 value amounting to $7.9 million.
- Protagonist Therapeutics' Accumulated Depreciation & Amortization rose 14.59% to $7.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year increase of 13.28%. This contributed to the annual value of $7.0 million for FY2024, which is 12.85% up from last year.
- As of Q3 2025, Protagonist Therapeutics' Accumulated Depreciation & Amortization stood at $7.9 million, which was up 4.76% from $7.6 million recorded in Q2 2025.
- In the past 5 years, Protagonist Therapeutics' Accumulated Depreciation & Amortization ranged from a high of $7.9 million in Q3 2025 and a low of $4.5 million during Q1 2022.
- Over the past 3 years, Protagonist Therapeutics' median Accumulated Depreciation & Amortization value was $6.7 million (recorded in 2024), while the average stood at $6.7 million.
- Over the last 5 years, Protagonist Therapeutics' Accumulated Depreciation & Amortization had its largest YoY gain of 21.37% in 2023, and its largest YoY loss of 6.44% in 2023.
- Over the past 5 years, Protagonist Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $5.8 million in 2021, then grew by 15.00% to $6.7 million in 2022, then decreased by 6.44% to $6.2 million in 2023, then climbed by 12.85% to $7.0 million in 2024, then rose by 14.59% to $7.9 million in 2025.
- Its Accumulated Depreciation & Amortization was $7.9 million in Q3 2025, compared to $7.6 million in Q2 2025 and $7.3 million in Q1 2025.